Výsledky vyhledávání

Akademický článek

Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis

Autor: Hua Jiang, Lu Li, Meiyu Guo, Meizhang Li, Hao Wu, Xiaomei Chen, Mingzhao Gao, Qianqian Xu, Jia Mi, Canchan Cui, Weijun Fu

Publikováno v: Hematology, Vol 29, Iss 1 (2024)

Background Renal insufficiency (RI) is a key factor affecting the prognosis of multiple myeloma (MM) patients. Because the benefit of daratumumab for treating MM patients with RI remains unclear, our objective was to evaluate the efficacy of daratumu

Externí odkaz: https://doaj.org/article/302e5dbd9ad74865a01f97feb11fa76a

Zobrazit plný text záznamu

Akademický článek

Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)

Autor: Gang An, Zheng Ge, Hongmei Jing, Jing Liu, Guoping Yang, Ru Feng, Zhongyuan Xu, Ming Qi, Jianping Wang, Juanjuan Song, Wei Zhou, Binbin Sun, Dian Zhu, Xi Chen, Canchan Cui, Lugui Qiu

Publikováno v: Blood Science, Vol 6, Iss 3, p e00193 (2024)

Despite recent progress in multiple myeloma (MM) treatments, most patients will relapse and require additional treatment. Intravenous daratumumab, a human IgGκ monoclonal antibody targeting CD38, has shown good efficacy in the treatment of MM. A sub

Externí odkaz: https://doaj.org/article/2ec97b8f16874c84a24dcc58cf904ec0

Zobrazit plný text záznamu

Akademický článek

Patient Journey Toward a Diagnosis of Light Chain Amyloidosis in a National Sample: Cross-Sectional Web-Based Study

Autor: Xuelin Dou, Yang Liu, Aijun Liao, Yuping Zhong, Rong Fu, Lihong Liu, Canchan Cui, Xiaohong Wang, Jin Lu

Publikováno v: JMIR Formative Research, Vol 7, p e44420 (2023)

BackgroundSystemic light chain (AL) amyloidosis is a rare and multisystem disease associated with increased morbidity and a poor prognosis. Delayed diagnoses are common due to the heterogeneity of the symptoms. However, real-world insights from Chine

Externí odkaz: https://doaj.org/article/75a616f6a3814de8ba164af5af2816e9

Zobrazit plný text záznamu

The patient journey toward a diagnosis of Light Chain Amyloidosis: findings from a social listening study (Preprint)

Autor: Jin Lu, Xuelin Dou, Yang Liu, Aijun Liao, Yuping Zhong, Rong Fu, Lihong Liu, Canchan Cui

BACKGROUND Systemic light chain (AL) amyloidosis is a rare and multi-system disease. Delayed diagnoses were common in AL amyloidosis, resulting in poor prognosis. OBJECTIVE To better understand the current situation and patient journey of AL amyloido

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47e5ed8c218862b6f4464068cffc385d
https://doi.org/10.2196/preprints.44420

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání